Eric Benevich
Chief Commercial Officer at Neurocrine Biosciences Inc (NBIX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 10SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 2,15464,408 held (−3%) | $154.61 | $333K | -12.2% |
| Dec 2SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 5,97044,893 held (−12%) | $151.74 | $906K | -10.6% |
- Sell
Chief Commercial Officer Eric Benevich sold $333K of NBIX at $154.61 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Eric Benevich sold $906K of NBIX at $151.74 — pre-scheduled 10b5-1 plan sale.